More symptomatic upper GI events with rofecoxib than celecoxib

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1072卷 / 1期

关键词：

Primary Care; Celecoxib; Rate Ratio; Thromboembolic Event; Rofecoxib;

D O I：

10.2165/00128415-200510720-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[1] Rofecoxib: fewer symptomatic GI events than meloxicam
Reactions Weekly, 2003, 957 (1) : 5 - 5
[2] GI events leading to death in association with celecoxib and rofecoxib
Weaver, J
Bonnel, RA
Karwoski, CB
Brinker, AD
Beitz, J
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (12): : 3449 - 3450
[3] Celecoxib, rofecoxib: age a risk factor for adverse GI events?
Reactions Weekly, 2002, 889 (1) : 3 - 3
[4] More adverse renal effects with rofecoxib than celecoxib
Reactions Weekly, 2002, 884 (1) : 4 - 4
[5] Rofecoxib affects BP control more than celecoxib
Reactions Weekly, 2002, 930 (1) : 4 - 4
[6] BP elevation more frequent with rofecoxib than celecoxib
Reactions Weekly, 2004, 1002 (1) : 4 - 4
[7] Rofecoxib: fewer adverse GI events than naproxen
Reactions Weekly, 2003, 976 (1) : 3 - 3
[8] Fewer GI complications with rofecoxib and celecoxib
Reactions Weekly, 2000, 804 (1) : 3 - 3
[9] Celecoxib and rofecoxib: risk of GI bleeding
Reactions Weekly, 2001, 882 (1) : 2 - 2
[10] Rofecoxib: lower rate of lower GI events than naproxen
Reactions Weekly, 2003, 944 (1) : 5 - 5

← 1 2 3 4 5 →